Literature DB >> 9765418

Effects of mutations in the rubella virus E1 glycoprotein on E1-E2 interaction and membrane fusion activity.

D Yang1, D Hwang, Z Qiu, S Gillam.   

Abstract

Rubella virus (RV) virions contain two glycosylated membrane proteins, E1 and E2, that exist as a heterodimer and form the viral spike complexes on the virion surface. Formation of an E1-E2 heterodimer is required for transport of E1 out of the endoplasmic reticulum lumen to the Golgi apparatus and plasma membrane. To investigate the nature of the E1-E2 interaction, we have introduced mutations in the internal hydrophobic region (residues 81 to 109) of E1. Substitution of serine at Cys82 (mutant C82S) or deletion of this hydrophobic domain (mutant dt) of E1 resulted in a disruption of the E1 conformation that ultimately affected E1-E2 heterodimer formation and cell surface expression of both E1 and E2. Substitution of either aspartic acid at Gly93 (G93D) or glycine at Pro104 (P104G) was found to impair neither E1-E2 heterodimer formation nor the transport of E1 and E2 to the cell surface. Fusion of RV-infected cells is induced by a brief treatment at a pH below 6. 0. To test whether this internal hydrophobic domain is involved in the membrane fusion activity of RV, transformed BHK cell lines expressing either wild-type or mutant spike proteins were exposed to an acidic pH and polykaryon formation was measured. No fusion activity was observed in the C82S, dt, and G93D mutants; however, the wild type and the P104G mutant exhibited fusogenic activities, with greater than 60% and 20 to 40% of the cells being fused, respectively, at pH 4.8. These results suggest that it is likely that the region of E1 between amino acids 81 and 109 is involved in the membrane fusion activity of RV and that it may be important for the interaction of that protein with E2 to form the E1-E2 heterodimer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765418      PMCID: PMC110290     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Oligomerization of glycolipid-anchored and soluble forms of the vesicular stomatitis virus glycoprotein.

Authors:  B Crise; A Ruusala; P Zagouras; A Shaw; J K Rose
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

2.  Time course of virus-specific macromolecular synthesis during rubella virus infection in Vero cells.

Authors:  M L Hemphill; R Y Forng; E S Abernathy; T K Frey
Journal:  Virology       Date:  1988-01       Impact factor: 3.616

3.  The heterodimeric association between the membrane proteins of Semliki Forest virus changes its sensitivity to low pH during virus maturation.

Authors:  J M Wahlberg; W A Boere; H Garoff
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

4.  Low pH-induced conformational change of rubella virus envelope proteins.

Authors:  S Katow; A Sugiura
Journal:  J Gen Virol       Date:  1988-11       Impact factor: 3.891

5.  Nucleotide sequence and in vitro expression of rubella virus 24S subgenomic messenger RNA encoding the structural proteins E1, E2 and C.

Authors:  D M Clarke; T W Loo; I Hui; P Chong; S Gillam
Journal:  Nucleic Acids Res       Date:  1987-04-10       Impact factor: 16.971

6.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

7.  Translocation of rubella virus glycoprotein E1 into the endoplasmic reticulum.

Authors:  T C Hobman; R Shukin; S Gillam
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

8.  In vitro and in vivo expression of rubella virus glycoprotein E2: the signal peptide is contained in the C-terminal region of capsid protein.

Authors:  T C Hobman; S Gillam
Journal:  Virology       Date:  1989-11       Impact factor: 3.616

Review 9.  A view of acidic intracellular compartments.

Authors:  R G Anderson; L Orci
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

10.  Expression of soluble forms of rubella virus glycoproteins in mammalian cells.

Authors:  T C Hobman; N O Seto; S Gillam
Journal:  Virus Res       Date:  1994-03       Impact factor: 3.303

View more
  10 in total

Review 1.  Rubella virus replication and links to teratogenicity.

Authors:  J Y Lee; D S Bowden
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Identification of the myelin oligodendrocyte glycoprotein as a cellular receptor for rubella virus.

Authors:  Haolong Cong; Yue Jiang; Po Tien
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

3.  Cell fusion activity of hepatitis C virus envelope proteins.

Authors:  S Takikawa; K Ishii; H Aizaki; T Suzuki; H Asakura; Y Matsuura; T Miyamura
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  Mutations in the E1 hydrophobic domain of rubella virus impair virus infectivity but not virus assembly.

Authors:  Z Qiu; J Yao; H Cao; S Gillam
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 5.  Molecular and Structural Insights into the Life Cycle of Rubella Virus.

Authors:  Pratyush Kumar Das; Margaret Kielian
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

6.  Cryo-electron tomography of rubella virus.

Authors:  Anthony J Battisti; Joshua D Yoder; Pavel Plevka; Dennis C Winkler; Vidya Mangala Prasad; Richard J Kuhn; Teryl K Frey; Alasdair C Steven; Michael G Rossmann
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

7.  Rubella virus: first calcium-requiring viral fusion protein.

Authors:  Mathieu Dubé; Felix A Rey; Margaret Kielian
Journal:  PLoS Pathog       Date:  2014-12-04       Impact factor: 6.823

8.  Assembly, maturation and three-dimensional helical structure of the teratogenic rubella virus.

Authors:  Vidya Mangala Prasad; Thomas Klose; Michael G Rossmann
Journal:  PLoS Pathog       Date:  2017-06-02       Impact factor: 6.823

9.  Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies.

Authors:  Ludmila Perelygina; Min-Hsin Chen; Suganthi Suppiah; Adebola Adebayo; Emily Abernathy; Morna Dorsey; Lionel Bercovitch; Kenneth Paris; Kevin P White; Alfons Krol; Julie Dhossche; Ivan Y Torshin; Natalie Saini; Leszek J Klimczak; Dmitry A Gordenin; Andrey Zharkikh; Stanley Plotkin; Kathleen E Sullivan; Joseph Icenogle
Journal:  PLoS Pathog       Date:  2019-10-28       Impact factor: 6.823

Review 10.  Animal and human RNA viruses: genetic variability and ability to overcome vaccines.

Authors:  T G Villa; Ana G Abril; S Sánchez; T de Miguel; A Sánchez-Pérez
Journal:  Arch Microbiol       Date:  2020-09-28       Impact factor: 2.552

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.